Please assess the completion status of the following clinical trial:

Trial Title: Ferumoxytol Versus Oral Iron in the Treatment of Anemia in Hemodialysis Patients

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Male or female patients ≥18 years.~* Chronic hemodialysis.~* Stable supplemental EPO therapy.~* Baseline hemoglobin of ≤ 11.5 g/dl.~Exclusion Criteria:~* Women who are pregnant or who are breast feeding.~* Received another investigational drug or device within 30 days.~* Recent parenteral or oral iron therapy.~* Patients with active GI bleeding or acute bleeding within 4 weeks. Patients that have other causes of anemia.~* Major surgery within 30 days or anticipated or planned surgery during the study.~* Patients with active infections.~* Recent blood transfusions.~* Patients with known allergies to iron products.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).